Summary Loss of heterozygosity (LOH) at several chromosomal loci is a common event in human malignancies. Frequent LOH on the long arm of chromosome 7 has been reported in various human malignancies, and investigators have identified the most common site of LOH as 7q31.1. We have identified ten chromosomal loci, including chromosome 7q, that have been shown by previous allelotype study to be sites of frequent LOH in differentiated adenocarcinoma of the stomach. In the present study, we performed a polymerase chain reaction (PCR) microsatellite analysis to define the common deleted region on 7q, using 14 polymorphic microsatellite markers in matched tumour and nontumour DNAs from 53 patients with primary gastric carcinoma of the differentiated type. LOH at any locus on 7q occurred in 34% (18 out of 53) of the tumours. Although many tumours exhibited total or large interstitial deletions, we determined the smallest common deleted region to be at D7S480 (7q31.1). This is identical to the region identified for other human malignancies. These observations indicate that a putative tumour suppressor gene at 7q31.1 may be involved in the pathogenesis of differentiated adenocarcinoma of the stomach.
Gastric carcinoma is the second most common cause of cancerrelated deaths in the world (Whelan et al, 1993) . The death rate for this malignancy in China, Eastern Europe, South America and Japan is much higher than in other parts of the world (Parker et al, 1996) . In Japan in particular, gastric carcinoma is the most common malignancy, with 47 000 Japanese dying of the disease in 1993 (Ministry of Health and Welfare, Japan).
Gastric carcinomas are classified histologically into differentiated and undifferentiated, and it is thought that these distinct histological types may develop through different genetic pathways (Tahara et al, 1993) . Some investigators have postulated that differentiated adenocarcinoma of the stomach may arise from a pre-existing adenoma Tahara, 1993) . However, the sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence have not been demonstrated in adenomas and differentiated adenocarcinoma of the stomach . These alterations include mutations of the APC (adenomatous polyposis coli), K-ras and p53 genes and deletion of the DCC (deleted in the colon carcinoma) gene (Vogelstein et al, 1988; Baker et al, 1990; Kikuchi-Yanoshita et al, 1992; Powell et al, 1992) . In addition, molecular analyses of gastric adenomas have demonstrated the genetic stability of this tumour type (Tamura et al, 1994; Maesawa et al, 1995) .
Frequent loss of heterozygosity (LOH) at a given chromosomal region has been interpreted as evidence that the affected region may contain a tumour-suppressor gene that is inactivated during the neoplastic process (Knudson, 1985) . In gastric carcinoma, frequent LOH has been reported on Ip, lq, 3p, 5q, 7q, lIp, llq, 12q, 17p, 18q and 21q (Sano et al, 1991; Uchino et al, 1992; Kuniyasu et al, 1994; Schneider et al, 1995; Baffa et al, 1996; Ezaki et al, 1996; Sakata et al, 1997) . Our recent allelotype analysis detected frequent LOH on 2q, 4p, Sq, 6p, 7q, llq, 14q, 17p, 18q and 21q in differentiated adenocarcinoma of the stomach (Tamura et al, 1996b) . The target of LOH on 17p is the p53 gene because concordant LOH with a mutation on the remaining allele, the classic two-hit mechanism for inactivation of tumour-suppressor genes (Knudson, 1985) , has been demonstrated (Tamura et al, 1991) . In addition, we have identified the minimum region of deletion on Sq and 21q by deletion mapping using polymorphic microsatellite markers (Tamura et al, 1996a; Sakata et al, 1997) .
It has been reported that the tumorigenicity of CH72, a cell line derived from a murine squamous cell carcinoma, was suppressed by the microcell-mediated introduction of human chromosome 7, suggesting that a tumour-suppressor gene may exist proximal to 7q31.1-31.3 (Zenklusen et al, 1994a) . Zenklusen et al (1995a) have attempted to determine the location of a putative tumour suppressor gene on 7q for several tumour types and have narrowed the locus down to a 1-cM region at 7q31.1. These studies have suggested the existence of a putative tumour-suppressor gene on 7q that is involved in the pathogenesis of a wide range of human malignancies. In the present study, we assessed LOH on 7q with polymorphic microsatellite markers to determine the common deleted region in differentiated adenocarcinoma of the stomach.
MATERIALS AND METHODS

Samples
Fifty-three carcinomas and corresponding non-tumour tissues were obtained surgically or endoscopically from 53 patients. A portion of the tissue was frozen and stored at -800C for DNA (Figure 1 ). Although many tumours (patients 20, 102, 110, 117, 134, 138, 66, 69, 124, 139, 147, 149 and 161) exhibited total or large interstitial deletions on 7q, including 7q31.1, we determined the minimum region of deletion to be at D7S480 (Figure 2 
DISCUSSION
Functional inactivation of a tumour-suppressor gene often involves deletion of the normal allele to unmask the mutated allele (Chen et al, 1994) . Chromosomal regions with frequent deletions are therefore thought to harbour putative tumour suppressors (Chen et al, 1994) . The pathogenesis of gastric carcinoma is not well understood, although many molecular genetic studies have been performed. Investigators have demonstrated chromosomal regions of deletion on ip, 3p, 5q, lq and 21q using polymorphic markers (Schneider, 1995; Baffa et al, 1996; Ezaki, 1996; Tamura et al, 1996a; Sakata et al, 1997) . These regions are thought to contain tumour-suppressor genes that influence the development and progression of gastric carcinomas. Cytogenetic studies have revealed 7q chromosomal abnormalities in several tumour types, including gastric carcinoma (Xiao et al, 1992; Takahashi et al, 1994; Gomyo et al, 1995; Visscher et al, 1996) . It has also been shown that intact human chromosome 7 can suppress the tumorigenicity of carcinoma cell lines (Zenklusen et al, 1994a) . From the clinicopathological point of view, there are reports that 7q LOH is a significant prognostic factor in some cancers (Bieche et al, 1992; Kuniyasu et al, 1994; Takahashi et al, 1995) . LOH on 7q has consequently been assumed to play a critical role in the development or progression of human malignancies.
The c-met proto-oncogene is located at 7q3 1.1. The c-met protein has been identified as the cell-surface receptor for hepatocyte growth factor (Bottaro et al, 1991) . LOH at 7q31.1 (c-met locus) has been reported in breast carcinoma and well-differentiated adenocarcinoma of the stomach (Bieche et al, 1992; Kuniyasu et al, 1994) . Zenklusen et al (1994b, c; 1995a, b) 1570 S Nishizuka et al to c-met at 7q3 1.1, with a normal distribution around the peak at D7S522. Moreover, Takahashi et al (1995) have found two distinct regions of deletion on 7q31 in prostate carcinomas. One was located within the 1-cM region between D7S523 and D7S486, and the other within the 3-cM region between D7S480 and D7S487 (Takahashi et al, 1995) . These observations suggest that putative tumour suppressor gene(s) for a wide range of human malignancies exist(s) at 7q3 1.1.
In the present study, we have analysed 7q LOH using 14 polymorphic microsatellite markers in an attempt to clarify the targeted locus that presumably contains a tumour suppressor gene important in gastric and other cancers. Although we found that many of the differentiated adenocarcinomas of the stomach exhibited total or large interstitial deletions on 7q that included 7q31.1, the smallest common deleted region was identified as the D7S480 locus. Although this region is located 1 cM from the smallest common deleted region determined previously (Zenklusen et al, 1994b (Zenklusen et al, , c, 1995a , it coincides with another region of frequent LOH nearest to the peak at D7S522 (Zenklusen et al, 1994b) . The smallest common deleted region at D7S480 is also identical to that determined by Takahashi et al (1995) . Therefore, the demonstration that the smallest common deleted region identified in this study coincides with that found in other tumours suggests that the same putative tumour suppressor gene contained within this region is involved in the development or progression of several common tumours, including differentiated adenocarcinoma of the stomach.
We found no significant correlation between 7q LOH and tumour stage or nodal metastasis. In contrast, Kuniyasu et al (1994) have demonstrated that deletion at D7S95 (7q31-35) was closely associated with tumour progression, especially with peritoneal dissemination of gastric carcinoma. As their samples consisted of both well-differentiated and poorly differentiated tumours, it would be difficult to compare these results. However, this phenomenon can be explained by hypothesizing that a cell adhesion molecule, such as E-cadherin, would be encoded by the putative tumour suppressor gene on 7q, because E-cadherin gene inactivation is associated with such disseminating tumour growth (Tamura et al, 1996c) and occurs even in its early stages (Muta et al, 1996) . However, as the analysis by Kuniyasu et al (1994) was limited to advanced carcinomas, the significance of LOH at D7S95 as an indicator of disseminated disease awaits a larger study.
In summary, the smallest common deleted region on 7q in differentiated adenocarcinoma of the stomach is located very close to that identified in other tumour types, and a major effort should be directed towards cloning the candidate gene.
